KRAS and breast cancer: Enrichment analysis revealed that the terms “epithelial-mesenchymal transition” and “KRAS signaling UP” were enriched in the upregulated genes, confirming that the MDA-MB-231 cells represent an aggressive and mesenchymal phenotype of breast cancer cells (Figure 1E).